This inventor holds 10 USPTO granted patents, plus 5 CIPO patents. Top assignees: Genkyotex Sa, Genkyotex Suisse Sa, Calliditas Therapeutics Suisse Sa. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Collonges-Sous-Salève, FR (2013 - 2015)
- Collonges-sous-Saleve, FR (2018 - 2020)
Company Filing History:
7 out of 13 
2 out of 3 
1 out of 3 Years Active: 2013-2026
Title: Benoit Laleu: Innovator in Pharmaceutical Chemistry
Introduction
Benoit Laleu is a notable inventor based in Collonges-sous-Salève, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of NADPH oxidase inhibitors. With a total of 10 patents to his name, Laleu's work has the potential to impact various medical treatments.
Latest Patents
One of Laleu's latest patents involves pyrazolo pyridine derivatives as NADPH oxidase inhibitors. This invention relates to pyrazolo pyridine derivatives of Formula (I), along with pharmaceutical compositions and their applications for treating or preventing disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). This innovative approach could lead to new therapeutic options for patients suffering from related conditions.
Career Highlights
Throughout his career, Benoit Laleu has worked with prominent companies in the pharmaceutical industry, including Genkyotex and Genkyotex Suisse. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.
Collaborations
Laleu has collaborated with various professionals in his field, including Patrick Naxos Page and Mike Orchard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Benoit Laleu's contributions to pharmaceutical chemistry, particularly through his patents on NADPH oxidase inhibitors, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile